[
    [
        {
            "time": "2023-11-27",
            "original_text": "俄允许使用未在俄注册的中国产羟氯喹治疗新冠患者或疑似患者",
            "features": {
                "keywords": [
                    "俄罗斯",
                    "羟氯喹",
                    "新冠",
                    "药品",
                    "治疗"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "俄允许使用未在俄注册的中国产羟氯喹治疗新冠患者或疑似患者",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]